Medrol 4 mg and 16 mg Tablets
PDF Leaflet Revision Date: 26 January 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Corticosteroid responsive diseases and various inflammatory conditions.
Dosage (summary)
Initial dosage varies from 4 to 48 mg/day; adjust based on response.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended; may cause fetal malformations and low birth weight.
Key Drug Interactions
- CYP3A4 inhibitors
- CYP3A4 inducers
- Warfarin
Contraindications
- Hypersensitivity to methylprednisolone
- Systemic fungal infections
- Traumatic brain injury
Common side effects
- Increased blood glucose
- Fluid retention
- Mood swings
Counselling Points
- Monitor for infections
- Do not stop abruptly
- Report mood changes
Serious warnings
- Increased susceptibility to infections
- Adrenal insufficiency risk
- Cushing's syndrome
Important Disclaimer
The Medrol 4 mg and 16 mg Tablets professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
